In the BioHarmony Drug Report Database

"Preview" Icon

Erythromycin

Akne-mycin, Eryc, Eryc Sprinkles, Erycette, Erygel, Erythromycin, Ilotycin, Pce, Staticin (erythromycin) is a small molecule pharmaceutical. Erythromycin was first approved as Akne-mycin on 1982-01-01. It is used to treat acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, and chancroid amongst others in the USA. It is known to target motilin receptor.

 

Trade Name

 

Akne-mycin, Eryc, Eryc Sprinkles, Erycette, Erygel, Erythromycin, Ilotycin, Pce, Staticin
 

Common Name

 

erythromycin
 

ChEMBL ID

 

CHEMBL532
 

Indication

 

acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, chancroid, chlamydia infections, erythrasma, gastroenteritis, gonorrhea, legionnaires' disease, mycoplasma infections, protozoan infections, staphylococcal infections, streptococcal infections, syphilis, urethritis, whooping cough
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Erythromycin structure rendering